Strategic Roadmap For Accomplishing The Unmet Demand Of COVID-19 Diagnostic Kits - Ingenious e-Brain
  • US | INDIA +1-202-697-9162 | +91-124-429-4218

Strategic Roadmap for Accomplishing the Unmet Demand of COVID-19 Diagnostic Kits

Since the declaration of COVID-19 by WHO as a pandemic on March 11, 2020, the outbreak is adversely impacting numerous individuals worldwide. Due to the low availability of test kits and sensitivity/specificity issues associated with a set of current kits, the number of cases is increasing exponentially.

This is a high time for molecular diagnostics companies and research facilities to re-strategizing their business decisions and develop future-fit strategies in this critical situation for meeting the current unmet demand for quality COVID-19 detection kits. Ingenious e-Brain calls molecular diagnostics leaders such as Agilent technologies to enter in the field of COVID -19 diagnostics by strategic collaboration with other existing players in the domain.

Why should you attend the webinar?

This webinar by Ingenious e-Brain will give practical tips to molecular diagnostics companies and research facilities on how to accelerate their business and overcome challenges associated with COVID-19 detection. Additionally, we will be sharing examples of best business practices and suggestions for leading the market.

  • To know about existing kits for the diagnosis of COVID-19
  • Get updated with current Testing/Diagnosis situation worldwide
  • Recognize all the primary road blockers to meet the current requirement in the domain
  • To find opportunities for growth within the COVID-19 diagnostic kit market
  • Recognize the market strategists in their respective decision-making process

Aired on:  27th May | 11 AM CEST    28th May | 11 AM EDT    2nd June | 11 AM CEST    3rd June | 11 AM EDT

Fill the form to join the webiner


Work Email *

Phone Number*


Job Title*


Webinar Date*